102 related articles for article (PubMed ID: 1987905)
21. Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy.
Goren MP; Wright RK; Pratt CB; Horowitz ME; Dodge RK; Viar MJ; Kovnar EH
Cancer Res; 1987 Mar; 47(5):1457-60. PubMed ID: 3815347
[TBL] [Abstract][Full Text] [Related]
22. Urinary trehalase activity and renal brush-border damage in inhabitants of a cadmium-polluted area (Jinzu River basin).
Nakano M; Aoshima K; Katoh T; Teranishi H; Kasuya M
Toxicol Lett; 1986 Dec; 34(2-3):159-66. PubMed ID: 3541290
[TBL] [Abstract][Full Text] [Related]
23. Direct amifostine effect on renal tubule cells in rats.
Weichert-Jacobsen KJ; Bannowski A; Küppers F; Loch T; Stöckle M
Cancer Res; 1999 Jul; 59(14):3451-3. PubMed ID: 10416609
[TBL] [Abstract][Full Text] [Related]
24. Elevation of urinary trehalase in mercuric chloride-induced nephrotoxic rabbits: urinary trehalase as a specific indicator of renal brush border damage.
Nakano M; Itoh G
Chem Biol Interact; 1983 Jul; 45(2):179-89. PubMed ID: 6224573
[TBL] [Abstract][Full Text] [Related]
25. Early detection of aminoglycoside nephrotoxicity with urinary beta-2-microglobulin.
Schentag JJ; Sutfin TA; Plaut ME; Jusko WJ
J Med; 1978; 9(3):201-10. PubMed ID: 84037
[TBL] [Abstract][Full Text] [Related]
26. [Cisplatin nephrotoxicity: effects on fractional excretion of sodium and enzymuria].
Cirami C; Bianchi AM; Galigani P; Gadducci A; Colombi L; Facchini V; Palla R
Minerva Med; 1990; 81(1-2):79-86. PubMed ID: 1969127
[TBL] [Abstract][Full Text] [Related]
27. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 1. Description of NAG activity determination].
Noto A; Mori S; Nakamura M; Kitakaze T
Rinsho Byori; 1983 Sep; Spec No 56():65-72. PubMed ID: 6663762
[No Abstract] [Full Text] [Related]
28. [Study on urinary splitting enzymes and proteins. III. Effect of non-ionic contrast medium on renal function].
Yasumoto R; Tanaka S; Asakawa M; Kakinoki K; Tanabe S; Nishisaka N; Mori K; Iseki T; Wada S; Maekawa M
Hinyokika Kiyo; 1989 Apr; 35(4):571-5. PubMed ID: 2567570
[TBL] [Abstract][Full Text] [Related]
29. [Studies on the mechanisms of renal damages induced by nephrotoxic compounds].
Yamada T
Nihon Hoigaku Zasshi; 1995 Dec; 49(6):447-57. PubMed ID: 8583688
[TBL] [Abstract][Full Text] [Related]
30. [Study on urinary beta-glucuronidase and alkaline phosphatase activities as indicators of CDDP renal toxicity].
Takahashi T; Yoshida K; Nakame Y; Saitoh H
Hinyokika Kiyo; 1989 Jan; 35(1):1-6. PubMed ID: 2729012
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
[TBL] [Abstract][Full Text] [Related]
32. [Changes on certain biochemical indexes for renal injury in workers exposed to lead].
Tian L; Zhao C; Li J; Lu X
Wei Sheng Yan Jiu; 2004 May; 33(3):343-4. PubMed ID: 15211809
[TBL] [Abstract][Full Text] [Related]
33. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
[TBL] [Abstract][Full Text] [Related]
34. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing.
Levi FA; Hrushesky WJ; Blomquist CH; Lakatua DJ; Haus E; Halberg F; Kennedy BJ
Cancer Res; 1982 Mar; 42(3):950-5. PubMed ID: 7199382
[TBL] [Abstract][Full Text] [Related]
35. Urinary trehalase activity in chronic glomerulonephritis.
Niwa T; Katsuzaki T; Yazawa T; Tatemichi N; Emoto Y; Miyazaki T; Maeda K
Nephron; 1993; 63(4):423-8. PubMed ID: 8096331
[TBL] [Abstract][Full Text] [Related]
36. [New treatments for urogenital toxicity of anti-neoplastic chemotherapy].
Shibuya M; Hirosawa A; Niitani H
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):950-6. PubMed ID: 2111664
[TBL] [Abstract][Full Text] [Related]
37. Comparison of methods of evaluating nephrotoxicity of cis-platinum.
Jones BR; Bhalla RB; Mladek J; Kaleya RN; Gralla RJ; Alcock NW; Schwartz MK; Young CW; Reidenberg MM
Clin Pharmacol Ther; 1980 Apr; 27(4):557-62. PubMed ID: 6987030
[TBL] [Abstract][Full Text] [Related]
38. Renal tubular function in patients treated with high-dose cisplatin.
Daugaard G; Abildgaard U; Holstein-Rathlou NH; Bruunshuus I; Bucher D; Leyssac PP
Clin Pharmacol Ther; 1988 Aug; 44(2):164-72. PubMed ID: 2840230
[TBL] [Abstract][Full Text] [Related]
39. [Effects of urinastatin against nephrotoxicity of cisplatinum].
Arakawa A; Kato N; Asai H; Yasui Y; Suzumori K; Suzumori K; Yagami Y
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2229-34. PubMed ID: 2241187
[TBL] [Abstract][Full Text] [Related]
40. Measurement of urinary beta 2-microglobulin in the detection of cisplatin nephrotoxicity.
Cohen AI; Harberg J; Citrin DL
Cancer Treat Rep; 1981; 65(11-12):1083-5. PubMed ID: 6170429
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
